The Polyglycolic acid is gaining attention in Indonesia as researchers explore advanced biodegradable materials for specialized applications. With properties such as high strength, biocompatibility, and controlled degradation, PGA is widely used in absorbable sutures and is being investigated for medical devices, tissue engineering, and drug delivery systems. Indonesia’s expanding healthcare infrastructure, rising demand for advanced treatments, and growing focus on domestic medical technology development are creating new opportunities for PGA-based solutions. The country’s medical device market is estimated at approximately USD 2.78 billion in 2025, supported by healthcare modernization and increasing adoption of medical technologies. 

Market Drivers Creating New Opportunities for PGA Adoption in Indonesia  

Medical Device Growth Supports PGA Application Development 

Indonesia’s expanding medical device sector is creating opportunities for advanced polymers such as PGA. The government is encouraging greater domestic production of healthcare products, with local medical equipment production increasing alongside efforts to reduce import dependence. PGA-based materials can support applications beyond surgical sutures, including temporary implants, controlled drug delivery systems, and regenerative medicine solutions. As healthcare manufacturers seek materials with improved performance and safety profiles, demand for specialized biodegradable polymers is expected to increase. 

Biotechnology Research Encourages Advanced Biomaterial Innovation 

Indonesia’s pharmaceutical and biotechnology sectors are gradually expanding research into advanced healthcare solutions. PGA and related biodegradable polymers such as PLGA are being explored for controlled drug release, tissue engineering, and regenerative applications. Increasing interest in improving healthcare outcomes and developing next-generation medical technologies is encouraging researchers and companies to explore innovative polymer-based solutions. 

Government Initiatives Supporting Indonesia's Polyglycolic Acid Industry 

Indonesia’s government is focusing on strengthening healthcare infrastructure, improving medical device availability, and promoting domestic manufacturing. Policies such as the Domestic Component Level (TKDN) framework encourage local production and reduce reliance on imported healthcare products. Regulatory oversight from the Ministry of Health ensures medical devices meet safety and quality standards, creating a structured environment for advanced biomaterial adoption. 

Competitors within Indonesia's Polyglycolic Acid Industry 

Indonesia’s PGA market includes international polymer suppliers, medical device manufacturers, healthcare companies, and research organizations. Companies are competing through product quality, customized formulations, technical expertise, and regulatory capabilities. As Indonesia develops its healthcare manufacturing ecosystem, collaborations between global biomaterial companies and local healthcare players are becoming increasingly important for introducing advanced PGA-based solutions. 

Market Challenges Affecting PGA Industry Growth in Indonesia  

Dependence on Specialized Materials Creates Supply Constraints 

Although Indonesia is strengthening its medical manufacturing capabilities, advanced biomaterials such as PGA still depend heavily on specialized production processes and international supply networks. Imported medical products continue to represent a significant portion of the market, creating challenges related to cost, availability, and supply chain reliability. 

High Costs and Regulatory Requirements Affect Adoption 

Medical-grade PGA requires advanced manufacturing, extensive testing, and regulatory approvals before commercialization. These requirements can increase investment needs and extend development timelines. Companies entering Indonesia’s market must develop strong technical capabilities, regulatory knowledge, and local partnerships to successfully introduce PGA-based healthcare solutions. 

Future Outlook 

In the upcoming years, Indonesia’s polyglycolic acid market is expected to benefit from healthcare modernization, medical device growth, and increasing interest in biodegradable materials. Absorbable sutures will remain a key application area, while opportunities in drug delivery, tissue engineering, and advanced medical devices can further expand PGA adoption. As Indonesia continues developing its healthcare ecosystem and strengthening local manufacturing capabilities, companies investing in polymer innovation, strategic partnerships, and specialized healthcare applications can find new opportunities in the country’s evolving biomaterials landscape. 

Consultants at Nexdigm, in their latest publication “Indonesia Polyglycolic Acid Market Outlook to 2035,” analyze the sector By Form Type (PGA Fibers, Films, Resin Plates, Rods and Composites), By End-Use Industry (Medical, Oil and Gas, Packaging and Civil Engineering), By Grade (Medical, Oilfield, Packaging, Industrial, High Performance and Biodegradable).  

Nexdigm suggests that businesses in Indonesia’s Polyglycolic Acid Industry should enhance supply chain capabilities, strengthen healthcare partnerships and expand applications across absorbable sutures, medical devices, drug delivery, and regenerative medicine to capture emerging market opportunities. 

To take the next step, simply visit our Request a Consultation page and share your requirements with us.  

Harsh Mittal  

+91-8422857704  

enquiry@nexdigm.com